Key result
Masked uncontrolled hypertension shows no difference in medication adherence compared to true controlled hypertension.
Why the study?
The study was conducted to determine whether masked uncontrolled hypertension (MUCH) is attributable to antihypertensive medication nonadherence.
Is masked uncontrolled hypertension (MUCH) attributable to antihypertensive medication nonadherence in treated hypertensive patients?
Cross-Sectional (n=158)
Patients were uninformed of adherence testing to prevent Hawthorne effect
No
Is masked uncontrolled hypertension (MUCH) attributable to antihypertensive medication nonadherence in treated hypertensive patients?
Masked uncontrolled hypertension represents an authentic physiologic phenomenon—such as heightened out-of-clinic sympathetic tone—rather than simply a reflection of poor medication adherence out of the clinic.
Answers are grounded in this paper and cite their sources.
Supports physiologic basis for MUCH beyond nonadherence; leaves open prospective validation before changing monitoring or adherence strategies.
Masked uncontrolled hypertension (MUCH) in treated hypertensive patients is defined as controlled automated office blood pressure (BP; <135/85 mm Hg) in-clinic but uncontrolled out-of-clinic BP by ambulatory BP monitoring (awake [daytime] readings ≥135/85 mm Hg or 24-hour readings ≥130/80 mm Hg). To determine whether MUCH is attributable to antihypertensive medication nonadherence. One hundred eighty-four enrolled patients were confirmed to have controlled office BP; of these, 167 patients were with adequate 24-hour ambulatory BP recordings. Of 167 patients, 86 were controlled by in-clinic BP assessment but had uncontrolled ambulatory awake BP, indicative of MUCH. The remaining 81 had controlled in-clinic and ambulatory awake BP, consistent with true controlled hypertension. After exclusion of 9 patients with missing 24-hour urine collections, antihypertensive medication adherence was determined based on the detection of urinary drugs or drug metabolites by high-performance liquid chromatography-tandem mass spectrometry. Of the 81 patients with MUCH, 69 (85.2%) were fully adherent and 12 (14.8%) were partially adherent (fewer medications detected than prescribed). Of the 77 patients with true controlled hypertension, 69 (89.6%) were fully adherent with prescribed antihypertensive medications and 8 (10.4%) were partially adherent. None of the patients in either group were fully nonadherent. There was no statistically significant difference in complete or partial adherence between the MUCH and true controlled groups (P=0.403). Measurement of urinary drug and drug metabolite levels demonstrates a similarly high level of antihypertensive medication adherence in both MUCH and truly controlled hypertensive patients. These findings indicate that MUCH is not attributable to antihypertensive medication nonadherence.
No takes yet. Share an insight, caveat, or question.
Siddiqui et al. (2019) conducted a cross-sectional in Masked uncontrolled hypertension (n=158). Masked uncontrolled hypertension (MUCH) vs. True controlled hypertension (controlled in-clinic and ambulatory BP) was evaluated on Full adherence to prescribed antihypertensive medications (detected by urinary LC-MS/MS) (p=0.403). Masked uncontrolled hypertension is not attributable to antihypertensive medication nonadherence, as full adherence rates were similar between patients with MUCH and true controlled hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: